Dr. Panchaxari M. Dandagi
M. PHARM Ph.D
PROFESSOR
DEPARTMENT OF PHARMACEUTICS.
KLE University’s COLLEGE OF PHARMACY
NEHRUNAGAR, BELGAUM- 590 010.
KARNATAKA, INDIA.
MISSION
Achieve academic excellence by educating and training the young
budding pharmacist, who has a major role to play in the healthcare
system.
OBJECTIVE
Train the UG & PG students to ensure high competence in the field
of pharmacy and prepare him/her for carrier in industry, research and
academics. Foster professional honesty and integrity, develop oral and
written communication skills, leadership skills and to have high moral
and ethical standards.
PARENTS
Late Shri. Mallappa N. Dandagi and
Smt. Mahadevi M. Dandagi
DATE OF BIRTH
: 15TH May 1965.
RESIDENCIAL ADDRESS
: A 13/2, Staff Quarters,
J.N.M.C. Campus. Nehru Nagar
BELGAUM - 590 010.
CONTACT @
: pmdandagi@yahoo.com
pmdandagi@rediffmail.com
PHONE/ FAX/ MOBILE Nos
: +91-831-2471399 [ ]
+91-831-2472387 []
+91-831-2471834 [Resi]
+91-9448527154 [Mobile]
PRESENT BASIC PAY
: 41963/-
FIELD OF INTEREST
Exploring and Developing of novel drug delivery systems including
nanopaticles, microspheres, microcapsules and colon delivery systems.
________________________________________________________________________
C.V of P .M. Dandagi
1
ACADEMIC QUALIFICATION
College/University Degree
University
Year
Result/
Class
70.80%
Field of
Specialization
Pharmacy
KLES College of B. Pharm
Pharmacy, Belgaum
Karnataka
University
Dharwad.
May
1991
Govt. College of M. Pharm
Pharmacy, Bangalore
Bangalore
University
May
1993
70.60%
Pharmaceutics
KLES College of Ph.D
Pharmacy, Belgaum
RGUHS
Bangalore
Feb
2009
Awarded
Herbal
Formulation
ACHIEVEMENTS
1. Secured Third Rank in B.Pharm Examination from Karnataka University,
Dharwad.
2. Qualified GATE-91 Examination with 99.07 Percentile.
PROFESSIONAL EXPERIENCE
: (Starting From Present Position)
College/University
Designation
Period
KLES College of Pharmacy,
Professor
01/04/2009
Belgaum.
To till date
KLES College of Pharmacy,
Professor & Head
01/10/2010 To
Belgaum.
30/04/2014
KLES College of Pharmacy,
Associate Professor
01-09-2005 To
Belgaum.
31/03/2009
KLES College of Pharmacy,
Assistant Professor
01-11-1999 To
Belgaum.
31-08-2005
KLES College of Pharmacy,
Lecturer
01-09-1996 To
Belgaum.
31-10-1999
KLES College of Pharmacy,
Lecturer
17-10-1994 To
31-08-1996
Hubli.
Sanjay Patil College of Pharmacy, Principal
02-08-1993 To
Sankeshwar.
29-09-1994
[D. Pharm College]
Total Teaching Experience: 19 Years
Total Research Experience: 13 Years
RESEARCH PUBLICATIONS AND PRESENTATIONS
Papers Published in Referred
Papers Presented in
#
Conferences @
Journals
55
57
43
12
{National]
[International]
# List Enclosed Annexure- I
@ List Enclosed Annexure- II
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-2
FELLOWSHIP OF ACADEMIC BODIES AND PROFESSIONAL SOCIETIES
Received Junior Research Fellowship [JRF] during the period between 1991 and
1993 At Government College of Pharmacy, Bangalore.
EXAMINERSHIP
1. Recognized by Rajiv Gandhi University of Health Sciences, Bangalore for
both Under Graduate and Post Graduate level since 1996.
2. Recognized by Shivaji University, Kolhapur.
3. Recognized by Bangalore University, Bangalore for Under Graduate level.
4. Recognized by Manipal University, Manipal
5. Recognized by Karnataka University, Dharwad for Under Graduate level.
6. Recognized by Goa University, Panjim for Under Graduate level.
MEMBERSHIP OF SCIENTIFIC AND PROFESSIONAL SOCIETIES

Life Member Indian Pharmaceutical Association [KTK/BEL/LM/023]

Life Member Association of Pharm Teachers of India [KA-LM/120]

Served as Treasurer, Scientific Society, KLES’s College of Pharmacy,
Belgaum.

Registered
Pharmacist
at
Karnataka
State
Pharmacy
Council,
Bangalore. Reg. No: 15591. Dated: 05/03/1993.

Served as Pharmacy Inspector by Karnataka State Pharmacy Council

Reviewer for Indian Journal of Pharmaceutical Education and
Research [IJPER] & RGUHS Journal of Pharmaceutical Sciences
[RJPS]

Member, LIC for Rajiv Gandhi University of Health Sciences, Bangalore.

Ex-Member, Board of Studies (BOS) for PG course ((2006-09) for Rajiv
Gandhi University of Health Sciences, Bangalore.
LIST OF CONFERENCES AND SHORT TERM COURSES ETC ORGANISED
OR PARTICIPATED

Participated in Controlled Release Societies International Conventions [03]
at At hotel Cidade-de-Goa, Panjim Goa on 19 & 20th Feb 1999, PERD Center,
Ahmedabad on 4, 5 & 6th Feb 2000. At Sci.Tech Center, Jogeshwari, Mumbai on
22 & 23rd 2002.

Delivered a Guest Lecture at RASASADHANA-05 organized by Shri B.M.
Kankanawadi Ayurved Mahavidyalaya, Belgaum on 20th January 2005.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-3


















Attended APTI National Conventions at Bangalore (2), Hubli, Nagpur and
Vishakapatnam
Actively Participated in 4th I.P.A National Convention on
Pharmaceutical Education, at KLES’s College of Pharmacy Belgaum on 25
& 26th Sept 1998.
Served as Treasurer L.O.C of 2ndGlobal Congress on Cosmetic
Technologies at KLES’s College of Pharmacy, Belgaum.
Attended as Delegate in One-Day workshop on Teaching Methodology
held at KLES’s College of Pharmacy Belgaum.
Served as Treasurer, L.O.C for 2nd International Symposium on Drug
Discovery and Process Research held at KLES’s College of Pharmacy,
Belgaum. On 10th –12th February 2006.
Served as Co-chairman of poster session at 60th IPC held at BHU Varanasi
(UP) 2008.
Attended and Participated in 3rd Congress on Cosmetic Technologies at
KLES’s College of Pharmacy, Belgaum.
Served as Convener for two weeks Quality Improvement Program on
“Quality Assurance of Pharmaceuticals Meeting a Major public health challenge
5th to 16th October 2009 at KLES College of pharmacy, Belgaum.
Served as Chairman of scientific session at 61st IPC at Ahmedabad 2009.
62nd IPC Manipal 2010 & 63rd IPC at Bangalore 2011
Organized as a Convener of two week Quality Improvement Programme
Current Status & Future Perspectives in Pharmaceutical Technology in 21st
March to 1st April 2011
Chaired oral session and Presented research paper at “International
conference on Pharmaceutical, Nutraceutical & Cosmaceutical Technology:
Formulations and Applications” held at Kuala Lumpur, Malaysia on 25, 26 &
27th of May 2010.
Participated as Souvenir committee chairman & also as co-chairman for
scientific session at “15th Annual conference & 1st International convention of
Society of Pharmacognosy” Organised by KLEU college of Pharmacy Belgaum
on 18th to 20th Feb 2011.
Attended Indian Pharmaceutical Congress (IPC) [09] at Goa, Bangalore,
Vishakapatnam, Mumbai, Pune, Chennai, Kolkota, BHU Varanasi(2007),
Ahmedabad(2009), Manipal (2010) & Bangalore (2011)
Two day National Seminar on QUALITY ASSURENCES IN HEALTH SCIENCE
INSTITUTIONS, Sponsored by NAAC. KLE University, Belgaum 2nd & 3rd Jan 2012
Organized as a Convener of two week Quality Improvement Programme
Challenges & Opportunities in Pharmaceutical Technology & Formulation
Development 20th to 31st January 2012
International workshop on Bioavailability & Bioequivalence, Organised by KLEU LDRI,
UCL Belgium, 8 – 9 Aug 2012
Indo- UK symposium, KLEU College of Pharmacy, Belgaum, 16/10/2012
Faculty evaluation workshop, KLEU UDEHP, 8th November 2012
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-4

Attended as delegate at RBF 6th International Symposium on Current Trends in
Pharmaceutical sciences organized by Zydus Research Centre, Ahmedabad on 4 to
6th February 2013.
CONSULTANCY AND SPONSORED RESEARCH ACTIVITIES
Year
Organization
Project Title
Amount
Received
1992-93
K.S.C.S.T.
Formulation and Evaluation of 5000/Bangalore
Controlled Release Beads of
Flurbiprofen Using Chitosan.
2003-04
R.G.U.H.S
Dexamethasone Matrix Tablets 10,000/Bangalore
For Colon Specific Delivery For
Inflammatory Bowel Disease.
RESEARCH ACTIVITY
Research guide for Post-graduate Students, approved by RGUHS, Bangalore,
since1999. Approval letter dated 19/05/99 Ref No-ACA/PGT-M.Ph/KLE/08/99-00/5583.
Till date guided 55 and co-guided 03 Post Graduate students [Completed]
At Present 06 students research work is in progress *.
* List enclosed Annexure- III
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-5
ANNEXURE -I
RESEARCH PUBLICATIONS
1.
“Formulation of a Transdermal Drug Delivery System of Ketotifen Fumarate” Indian Journal of
Pharmaceutical Sciences; 2003, 65 (3), 239-243.
2. “Development and Evaluation of Ketorolac Tromethamine Ocular Films” Indian Drugs, 2003,
40 (6), 369-371.
3. “Development and Evaluation of Ocular Films of Cromolyn Sodium” Indian
Journal of
Pharmaceutical Sciences; 2004, 66 (3), 309-312.
4. “Microencapsulation of Verapamil HCl By Ionotropic Gelation Technique” Indian Journal of
Pharmaceutical Sciences; 2004, 66 (5), 631-635.
5. “Taste Masked Oflaxacin Mouth Disintegrating Tablets” Indian Drugs 42 (1) 2005, 52-55.
6. “Development and Evaluation of Theophylline and Salbutamol Sulphate Sustained Release Matrix
Tablets”, Indian Journal of Pharmaceutical Sciences, 2005(67 (05), 598-602.
7. “Formulation and In vitro evaluation of Diltiazem Hydrochloride buccal films”. The Indian
Pharmacist, IV (37) July 2005, 59-62.
8. “Orodispersible Tablets: New-Frangled Drug Delivery System” Indian Journal of
Pharmaceutical Education and Research, 39 (04), Oct-Dec2005, 177-181.
9. “Biodegradable Microparticulate System of Captopril” International Journal of Pharmaceutics,
2006, 307 (01), 83-88.
10. “Formulation and Evaluation of Ondansetron HCl Directly Compressed Mouth Disintegrating
Tablets” Indian Drugs, 2006, 43(1), 35-37.
11. “Formulations and Evaluation of Ornidazole Dental Implants for Periodontitis”, Indian Journal
of Pharmaceutical Sciences, 2006 68(1), 68-71.
12. “Non-Chewable Antacid Formulations: Effect of Different Disintegrating Agents on Their Acid
Neutralization Properties” Indian Journal of Pharmaceutical Sciences, 2006, 68(2), 269-273.
13. “Rapidly disintegrating Domperidone Tablets”, Indian Drugs, 2006, 43 (7) 594-597.
14. "Time and pH Dependent Colon Specific, Pulsatile Delivery of Theophylline for Nocturnal
Asthma" International Journal of Pharmaceutics. 2007, 328(2),49-56.
15. “Mucoadhesive microspheres of Propranolol HCl for nasal delivery” Indian Journal of
Pharmaceutical Sciences, 2007, 69(3), 402-408.
16. “Antiulcer activity of extracts of Cyperous rotundus rhizome in pylorus ligated rat model”.
Advances in Pharmacology and Toxicology, 2007, 8(3), 117 – 122.
17. “Antihypertensive activity of seeds of Mucuna prurunes in dexamethasone induced hypertension
in rats” Advances in Pharmacology and Toxicology, 2007, 8(3), 59 – 62.
18. “Antidiabetic activity of fruits Punica granatum and seeds of Mucuna prurunes in alloxan induced
diabetic rats”. International journal of Pharmacology and Biological Sciences, 2007, 1(3),
29-32
19. "In vitro in vivo evaluation of Ranitidine HCl ethyl cellulose floating microparticles” Journal of
Microencapsulation, 2008: 13(3): 1-8.
20. “Antiulcer activity of extracts of Calotropis gigantean roots in pylorus ligated rat model”.
International journal of Pharmacology and Biological Sciences, 2008, 2(1), 127 – 132.
21. “Development and Evaluation of Hepatoprotective Polyherbal Formulation Containing Some
Indigenous Medicinal Plants” Indian Journal of Pharmaceutical Sciences, 2008, 70(2), 265268.
22. “Antidiabetic activity of flower buds of Hibiscus rosa sinensis and leaves of Moringa olefera in
alloxan induced diabetic rats” Advances in Pharmacology and Toxicology, 2008, 9(2), 99 –
103.
23. “Design and evaluation of bilayer floating gastro-retentive tablets for the controlled delivery of
Clarithromycin” International journal of Pharmacology and Biological Sciences 2009, 3(1),
27-34.
24. “Floating bilayer tablet for drug delivery system containing Cefpodoxime proxetil for prolonged
gastric residence” J. Chemical and Pharmaceutical Sciences Vol. 2 (1) Jan – Mar 2009, 3844.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-6
25. “Sodium Alginate Polymeric Floating Beads for the Delivery of Cefpodoxime Proxetil” Journal
of Applied Polymer Science 2009; 114(3), 1921-26.
26. “Polymeric ocular Nanosuspension for controlled release of acyclovir: in vitro release and ocular
distribution”. Iranian Journal of Pharmaceutical Research 2009, 8 (2): 79-86
27. “pH- Sensitive Mebaverine microspheres for colon delivery” Indian Journal of Pharmaceutical
Sciences, 2009, 71(4), 464-68
28. “Controlled Release Polymeric Ocular Delivery of Acyclovir” Pharmaceutical Development
and Technology, 2010, 15(4), 369-378.
29. Preparation and evaluation of Sparfloxacin Dental Implants for treatment of periodontal diseases.
International Journal of Pharm Sciences, 2010 2(2), 606-611
30. Development and characterization of a particulate drug delivery system for Etoposide, Indian
Journal of Novel Drug Delivery 3(1), Jan-Mar, 2011, 43-51
31. Design and Evaluation of Aceclofenac Loaded Microsponge for Topical Delivery. Journal of
Pharmaceutical Research & Clinical Practice, Apr-June 2011; 1(2):90-101
32. Enhancement Of Solubility And Dissolution Property Of Griseofulvin By Nanocrystallization, Int.
J. Drug Dev. & Res., April-June 2011, 3 (2): 128-139
33. Oral osmotic drug delivery system- An update, International journal of research in
pharmaceutical sciences. 2011, 2(2), 225-236.
34. Formulation and Evaluation of Floating Microspheres of Captopril for Prolonged Gastric
Residence Time, Indian Journal of Novel Drug Delivery 3(1), Jan-Mar, 2011, 17-23.
35. Development and Characterization of a Particulate Drug Delivery System for Etoposide, Inventi
Impact: NDDS Vol. 2011, Issue 1, 36-41
36. Design and Characterization of Clotrimazole Nanoparticles: An Approach to Controlled Drug
Delivery, Inventi Impact: NDDS Vol. 2011, Issue 1, 22-26.
37. Formulation And Evaluation Of Metoclopramide Rapidly Disintegrating Tablets, Journal of Drug
Delivery & Therapeutics; 2011, 1(2): 10-14
38. Development & charecterization of chronomoduted drug delivery system of Captopril.
International journal of Pharmaceutical investigation, 2011, 1(4), 227-233.
39. Formulation And Effect Of Viscosity And Concentration Of Methocel On Release Characteristics
Of Trimetazidine Matrix Tablets, International Journal of Pharmacy and Pharmaceutical
Sciences 2012, Vol 4, Issue 1, 230-5
40. Fabrication And In Vitro Evaluation Of Porous Osmotic Pump Based Controlled Drug Delivery
Of Metoprolol Succinate, Int J Pharm Pharm Sci, 2012 Vol 4, Issue 3, 697-704
41. RES & brain targeting stavudine-loaded solid lipid nanoparticles for AIDS therapy, Asian Journal
of Pharmaceutics, 2012, 6, 116-23.
42. Effect of verious superdisintegrants on the drug release profile & disintgration time of
Metaproterenol sulphate orally disintegrating tablets. International Journal of Biological &
Pharmaceutical Research. 2012; 3(1): 169-176.
43. Design & Characterization of diclofenac diethylamine transdermal patch using silicone & acrylic
adhesive combination. DARU Journal of Pharmaceutical Sciences. 2013, 21:6.
44. Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the
An Formulation of Ocular Mucoadhesive Microspheres. Scientia Pharmaceutica 2013; 81:
259–280
45. Formulation and Evaluation of Proniosome Based Drug Delivery System of the Antifungal Drug
Clotrimazole International Journal of Pharmaceutical sciences & Nanotechnology 2013, 6
(1), 1945-51
46. Formulation of trimetazidine matrix tablet using methocel and effect of different parameters on
drug release from matrix tablet Turkish Journal of Pharm Sciences 2013,10 (2), 287-302.
47. Nanofibres: Fabrication, charecterization & their biomedical applications, Indian Drugs
Aug2013: 50(08)
48. Formulation and Evaluation of Itopride Hydrochloride Floating Beads for Gastroretentive
Delivery International Journal of Pharmaceutical Sciences and Nanotechnology. 2013Vol
6; Issue 4 : 2225-2239
49. Recent advancements & developments in floating drug delivery system- An approach for
Gastroretention. Indian Drugs 2013, 50(12), 5-20
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-7
50. Studies on formulation & evaluation of osmotically controlled DDS of carbimazepine,
International Journal of Pharmacy & Pharm Sciences 2014, 6, (2) 239-250
51. Formualtion & In vivo evaluation of poorly soluble Deferosirox dispersible tablets by HP beta
Cyclodextrin complexation, International Journal of Pharmacy & Pharm Sciences, 2014, 6
(2) 251-256
52. Isolation and charecterization of Exopolysaccharides from lactic acid bacteria and its use in
formulation development, Indian Drugs February 2014: 51(02), 39-45
53. Formulation and evaluation of nanostructured lipid carrier (NLC) of Lornoxicam International
Journal of Pharmacy & Pharm Sciences, 2014, 6 (2), 73-77
54. Thermosensitive gels containing carbamazepine microspheres for intranasal brain targeting.
World journal of Pharmaceutical Research, 2014, 3 (9) 716-730.
55. Taste masked quinine sulphate loaded solid lipid nanoparticles for flexible pediatric dosing.
Indian Journal of Pharmaceutical Education & Research 2014, 48(12 suppl.) 93-99
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-8
ANNEXURE -II
REASERCH PRESENTATIONS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
“Application of Chitosan as Carrier for Oral Controlled Release Dosage Form” 47Th Indian
Pharmaceutical Congress, Vishakapatnam [AP] on 27-29th Dec 1995.
“Transdermal Films of Salbutamol Sulphate: Effect of Permeation Enhancers” 52nd Indian
Pharmaceutical Congress Hyderabad [AP] on 18-20th Dec 2000.
“Development and Characterization of Transdermal Films of Ketotifen Fumarate using Ethyl
Cellulose and HPMC” 4th International Symposium on Controlled Release Society, SciTech Centre,
Mumbai. 22 & 23rd Feb 2003.
“Effect of Enhancers on Drug Release Kinetics of Transdermal Films of Ketotifen Fumarate” 4th
International Symposium on Controlled Release Society, SciTech Centre, Mumbai. 22 & 23rd Feb 2003.
“Development and Evaluation of Ocular Films of Cromolyn Sodium” 54Th Indian Pharmaceutical
Congress, Pune on 13, 14 &15 Dec 2002.
“Development of Mucoadhesive Tablets for Oral Controlled Release of Astemizole” 8Th APTI
National Convention Hubli. 17 & 18th Oct 2003.
“Transdermal Films of Terbutaline Sulphate; Effect of Plastisizer on Drug Release Kinetics” 8Th
APTI National Convention, Hubli. 17 & 18th Oct 2003.
“Development of Wound Healing Herbal Formulation from Petroleum Ether Extract of Coctus
Speciosus” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13,14 &15 Feb 2004.
“Development of Wound Healing Herbal Formulation from Benzene Extract of Curcuma
Domestica” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13, 14 &15 Feb 2004.
“Development of Wound Healing Herbal Formulation from Benzene Extract of Terminalia
Chebula” 2nd Global Congress on Cosmetic Technologies, Belgaum. 13, 14 &15 Feb 2004.
“Design, Formulation and Comparative Evaluation of Thiophylline and Salbutamol Sulphate Matrix
Tablets” International Convention of APTI 2004, at Vishakapatnam, AP, 2nd and 3rd October 2004.
“Dexamethasone Matrix Tablets For Colon Specific Delivery Using Guar Gum” at 56th IPC
Kolkata, 4th Dec 2004.
“Formulations and Evaluation of Ornidazole Dental Implants for
Periodontitis” at 56th IPC
th
Kolkata, 4 Dec 2004.
“Flurbiprofen Microbeads for Controlled Release” International Convention of APTI 2004, at
Vishakapatnam, AP, 2nd and 3rd October 2004.
Presented a Paper in National Seminar and Workshop on Rasashastra-2005 organized by KLES
Shri B. M. Kankanwadi Ayurvedic Mahavidyalaya, Belgaum on 19th and 20th January 05.
“Development of Sparfloxacin dental implants for treatment of Periodontal Diseases. 57th IPC held
at Hyderabad on 1 to 3 Dec 2005.
“Development of Moxifloxacin dental implants for treatment of Periodontal Diseases” 10th APTI
National Convention at Nagpur on 17th and 18th Oct 2005.
“Development and Evaluation of herbal formulation of Commiphora mukul plant extract” at 57th
Indian Pharmaceutical Congress held at Hyderabad on 1 to 3 Dec 2005.
“Colon Specific Delivary of a Cox2 Preferential inhibiter” at 2nd International Symposium on Drug
Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Formulation and Evaluation of pH Dependent Eudragit Microcapsules for colon targetting” at
2nd International Symposium on Drug Discovery and Process Research, KLES College of Pharmacy
Belgaum on 10th to 12th Feb 2006.
“Influence of ɑ-Cyclodextrine on Solubility of Acyclovir” at 2nd International Symposium on Drug
Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Formulation and Evaluation of Bromhexine CR Tablets” at 2nd International Symposium on Drug
Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Development and Evaluation of Hepatoprotective Polyherbal Formulation” at 2nd International
Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to
12th Feb 2006.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
-9
24. “Formulation and Charecterisation of Mucoadhesive Microspheres of Propranolol HCl for nasal
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
Delivery” at 2nd International Symposium on Drug Discovery and Process Research, KLES College of
Pharmacy Belgaum on 10th to 12th Feb 2006.
“Effect of Tween 20 and Tween 40 on 5-Flurouracil niosomes” at 2nd International Symposium on
Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Design and Charecterisation of Orodispersible Valdecoxib Tablets” at 2nd International
Symposium on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10 th to 12th
Feb 2006.
“Design and charecterisation of floating microspheres of an antiulcer drug: an approach to oral
controlled drug delivary via gastric retention” at 2nd International Symposium on Drug Discovery and
Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Formulation and Evaluation of Polyherbal Antidiabetic Preparation” at 2nd International Symposium
on Drug Discovery and Process Research, KLES College of Pharmacy Belgaum on 10th to 12th Feb 2006.
“Antiulcer Activity of extracts of Cyperous rotundas a national level Symposium SYNAPSE-2007
held at College of Engineering and Technology, Belgaum, on 27th and 28th March 2007.
“Design and evaluation of Acyclovir ocular inserts for once a day therapy- A novel approach”
59th IPC, BHU, Varanasi on 20th-23rd Dec 2007.
“Design and Charecterization of pH-sensitive microspheres of Mebaverine for Colon Delivery”
60th IPC, New Delhi, 12-14th Dec 2008.
“Clotrimazole engineered Poly-lactide-co-glycolide nanoparticles” Young Researchers Conference09, Institute of Chemical Technology, Mumbai. 27-28th January 2009.
“Design & characterization of colon targeted nimesulide double coated tablets for the
prophylaxis of colon cancer” 61st IPC, Ahmedabad, 11th-13th Dec 2009.
“Design & Characterization of pH sensitive microspheres of mebaverine for colon delivery” 61st
IPC, Ahmedabad, 11th-13th Dec 2009.
“Nanocrystallization As An Approach To Enhance Dissolution Of Griseofulvin” Pharmatech
2010 at Kuala Lumpur, 25- 27th May 2010
“Development and Characterization Of A Particulate Drug Delivery System For Etoposide”
Pharmatech 2010 at Kuala Lumpur, 25- 27th May 2010.
“Formulation & Release study of Trimetazidine Matrix Tablets using Methocel” Indian
Pharmaceutical Congress at Manipal December 2010. (mihir)
“Enhancement of solubility & dissolution property of Griseofulvin by Nanocrystallization” Indian
Pharmaceutical Congress at Manipal December 2010.(sumit)
Formulation And In Vitro Evaluation Of Mucoadhesive Microcapsules Of Aceclofenac For Oral
Controlled Release, 63rd IPC Bangalore 16- 18 Dec 2011 (Patel Chirag P.)*
Design and Optimization of Delayed Release Pellets using Response Surface Methodology, 63rd
IPC Bangalore 16- 18 Dec 2011 (Girish. B),
Formulation And Evalution Of Non-Steroidal Anti-Inflammatory Drug Loaded Microsponge For
Topical Delivery, 63rd IPC Bangalore 16- 18 Dec 2011 (Pandey C.K.)*,
Design And Evaluation Of Aceclofenac Loaded Microsponge For Topical Delivery, 63rd IPC
Bangalore 16- 18 Dec 2011 (Nagratna.G.Dhople),
Formulation Development And Evaluation Of Colon Targeted Beads Of Mesalamine, 63rd IPC
Bangalore 16- 18 Dec 2011 (Suryasri Lavanya Adavi),
Design & characterization of flurbiprofen loaded polymeric nanosuspension for opthalmic
application, Current status & Future perspective in pharmaceutical sciences, Organised by PES
College of Pharmacy Bangalore, 20th & 21st July 2012 (Mr. Girish B)
Nasal insitu gel of Metaproternol sulphate : Development and ex vivo evaluation. 64th Indian
pharmaceutical congress, 7th to 9th December 2012.
Proniosome based drug delivery system of Clotrimazole. 64th Indian pharmaceutical congress,
7th to 9th December 2012.
Formulation and evaluation of ocular mucoadhesive microspheres of Moxifloxacin
Hydrochloride. 64th Indian pharmaceutical congress, 7th to 9th December 2012.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
- 10
48. Preparation of itopride hydrochloride floating Beads for gastroretentive delivery by the emulsion
49.
50.
51.
52.
53.
54.
55.
56.
57.
Gelation method and evaluation of their in-vitro and In-vivo characteristics, 65th Indian
Pharmaceutical Congress, Noida Delhi, 20th to 22nd December 2013
Formulation and evaluation of cinnarizine floating Beads, 65th Indian Pharmaceutical Congress,
Noida Delhi, 20th to 22nd December 2013
Design and characterization of diclofenac diethylamine in adhesive type transdermal, 65th Indian
Pharmaceutical Congress, Noida Delhi, 20th to 22nd December 2013
isolation and characterization of exopolysaccharides from lactic acid bacteria and its application
in formulation development, 65th Indian Pharmaceutical Congress, Noida Delhi, 20th to 22nd
December 2013
Formulation and evaluation of extended release tablets of glipizide 65th Indian Pharmaceutical
Congress, Noida Delhi, 20th to 22nd December 2013
Development of hollow/porous floating beads of metoprolol for pulsatile drug delivery, 65th
Indian Pharmaceutical Congress, Noida Delhi, 20th to 22nd December 2013
Studies on formulation and evaluation of osmotically controlled drug delivery system of
carbamazepine, 65th Indian Pharmaceutical Congress, Noida Delhi, 20th to 22nd December 2013
Formulation and evaluation of dispersible tablets of deferasirox, 65th Indian Pharmaceutical
Congress, Noida Delhi, 20th to 22nd December 2013
Isolation and purification of exopolysaccharides, 65th Indian Pharmaceutical Congress, Noida
Delhi, 20th to 22nd December 2013
And exploring its potential as an excipient in the Development of suitable formulation, 65th
Indian Pharmaceutical Congress, Noida Delhi, 20th to 22nd December 2013
58.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
- 11
ANNEXURE -III
TITLES OF PG. DISSERTATION WORK
01. Development and characterization of a buccoadhesive dosage form of propranolol hydrochloride.
[Sajan Jose, 1998]*
02. Formulation and in vitro release study of oral extended release Verapamil Hydrochloride tablet
from various cation exchange resins. [Anurag varma, 1998]*
03. Development of Mucoadhesive tablets for oral controlled release of Astemizole. [Abhay Pawar,
1998]*
04. Development and evaluation of Transdermal films of Nifedipine. [Sandeep Singhvi, 1999]
05. Studies on sustained release Diltiazem matrix tablets and effect of binders on drug release.
[Venkatesh.J.S, 1999]
06. Development and evaluation of ocular films of Cromolyn Sodium. [Rahul Rathod, 2000]
07. Development and evaluation of Transdermal films of Salbutamol Sulphate. [Yuvraj Singh, 2000]
08. Transdermal films of Terbutaline Sulphate and effect of Plastisizer type and concentration on
release kinetics. [Abhay Joshi, 2001]
09. Preparation and evaluation of diclofenac sodium ocular inserts using ethyl cellulose and cellulose
acetate. [Swapnil Phade, 2001]
10. An approach to the formulation of a TDDS of Ketotifen Fumarate. [Jagadeesh. T, 2002]
11. Development and evaluation of Ketorolac Tromethamine ocuserts. [Balasaheb. Wagh, 2002]
12. Formulation and in vitro charecterization of Diltiazem HCl films for Buccal Patches. [Thomas.
P.T, 2002]
13. Microencapsulation of Verapamil HCl by ionotropic gelation technique. [Balamuralidhara. V,
2003]
14. Design and evaluation of polymeric ocular drug delivery system for controlled release of
Flurbiprofen sodium. [Sarvesh Malviya, 2003]
15. Taste masked ofloxacin mouth dissolve tablets. [Sreenivas. S.A, 2004]
16. Dexamethasone matrix tablets for colon specific delivery for inflammatory bowel diseases.
[Ravindra Singh, 2004]
17. Design, formulation and comparative evaluation of theophylline and Salbutamol Sulphate matrix
tablet for SR combined dosage form. [Ruchi Sharma, 2004]
18. Formulation and evaluation of Domperidone rapidly disintegrating tablets. [Prabhu. K.H, 2005]
19. Biodegradable micro particulate system of Captopril. [Manish Kumar. G, 2005]
20. Preparation and evaluation of Sparfloxacin dental implants for treatment of periodontal diseases.
[Sujata. D, 2005]
21. Development and evaluation of hepatoprotective polyherbal formulation. [Rajakumar
Dhumansure, 2006]
22. Design and characterization of colon targeted Nimesulide double-coated tablets for the
prophylaxis of colon cancer. [Shaik Mohd. Asif, 2006]
23. Formulation and characterization of Mucoadhesive microspheres of propranolol for nasal
delivery. [Sudhir Iliger, 2006]
24. Design and evaluation of acyclovir ocular inserts for once a day therapy- A novel approach.
[Praful Deshpande, 2006]
25. Formulation and Characterization of Famotidine Floating Microspheres. [Senthilkumar. R 2007]
26. Formulation and Characterization of Acyclovir loaded Nanosuspensions for Ophthalmic Delivery.
[Shashidhar Kerur 2007]
27. Design and Characterization of Clotrimazole Nanoparticles- An approach to controlled Drug
Delivery. [Sandeepkumar April 2008]
28. Design and Characterization of pH sensitive microspheres of Mebaverine for colon delivery.
[Bharamappa Konnur April 2008]
29. Formulation and evaluation of Metaclopramide rapidly disintegrating tablet [Shashank J. Mohite
Feb 2009]
30. Formulation and evaluation of Pilocarpine loaded Chitosan nanoparticles. [Bheemanna Munnur
Feb 2009]
31. Formulation and Evaluation of Extended release Tablets of Ranolizine by solvent free hot melt
coagulation Technique. [Ms Jignaben Umeshbhai Patel April 2010]
________________________________________________________________________
C.V of Dr. P .M. Dandagi
- 12
32. Formulation and in vitro evaluation of taste masked orodispersible tablets of levocetirizine. [Mrs
Sumati Suresh Puri April 2010]
33. Enhancement of solubility and dissolution properties of Griseofulvin by nanocrystallization
technique. [Mr. Shaktish Telsang April 2010]
34. Formulation and In Vitro evaluation of Aceclofenac Microcapsules for oral controlled release.
[Mr. Divyanshu S. Raval May 2010]
35. Design & Evaluation of Acelofenac loaded microsponge for topical delivery [Mr. Mihir Upadhyay].
36. Development & evaluation of solid lipid nanoparticles containing anti retroviral- stavudine [Mr.
Punit D Patel].
37. Formulation development & evaluation of colon targeted beads of mesalamine[Mr. Sumit
Kaushik].
38. Fabrication & in vitro evaluation of porous osmotic pump based controlled drug delivery of
metoprolol succinate [Mr. Koradia Navik].
39. Design & characterization of Flurbiprofen loaded polymeric nanosuspension for ophthalmic
application [Mr. Mayank M. Sanghvi].
40. Formulation and evaluation of ocular bioadhesive microspheres of moxifloxacin hydrochloride
[Mr. Amit Belekar]
41. Design and characterization of diclofenac diethylamine in adhesive type transdermal therapeutic
system [Ms. Saujanya P.]
42. Proniosomes as a carrier for transdermal delivery of clotrimazole [Mr. Pankaj Shukla]
43. Thermoreversible mucoadhesive gel for the nasal delivery of metaproterenol sulfate for the
management of bronchospasm [Ms. Rini Thomas]
44. pH dependent, time delayed, microbially triggered in-layered tablets of 5-flurouracil for colon
targeting [Mr. Anilkumar AVS]
45. Formulation and evaluation of dispersible tablets of deffrasirox. [Ms. Suryasri Lavanya Adavi]
46. Formulation and evaluation of itopride hydrochloride floating beads for gastroretentive delivery.
[Ms. Nagaratna Dhople]
47. Formulation and evaluation of nanostructrued lipid carriers of lornoxicam. [Ms. Gayathri Dessai]
48. Development of hollow/porous floating beads of metoprolol for pulsatile drug delivery. [Mr.
Sangamesh Taranalli]
49. Studies on formulation and evaluation of osmotically controlled drug delivery system of
carbamazepine. [ Mr. Chirag Patel]
50. Formulation and evaluation of quinine sulphate loaded solid lipid nanoparticles ms. [Rath.
Seeprarani 2014]
51. Thermosensitive gels containing carbamazepine microspheres for intranasal brain targeting [mr.
Rohit sharma 2014]
52. Development and evaluation of topical formulation containing serratiopeptidase [Ms. Sayani
konar 2014]
53. Formulation and evaluation of oral strip of ziprasidone hydrochloride. [mr. Vaibhav desai 2014]
54. Studies on formulation and evaluation of lornoxicam microsponges for oral drug delivery [ms.
Nori pavani pallavi 2014]
55. Preparation and in-vitro evaluation of mucoadhesive buccal tablets of ketorolac tromethamine
[mr. Ailineni Anjthrao 2014]
* As Co-guide.
________________________________________________________________________
C.V of Dr. P .M. Dandagi
- 13